Seizures as a rare but serious adverse effect of leukotriene receptor
Access
info:eu-repo/semantics/closedAccessDate
2016Author
Erdem, Semiha BahçeciKaraman, Sait
Nacaroğlu, Hikmet Tekin
Karkıner, Canan Şule Ünsal
Yazıcı, Selçuk
Can, Demet
Metadata
Show full item recordAbstract
Leukotriene receptor antagonists (LTRAs) are used widely in the treatment of allergic rhinitis and asthma in children.1,2 LTRAs are safe in combination with antihistamines in patients with chronic urticaria who respond inadequately to antihistamines alone.3 Several clinical trials have emphasized that LTRAs can be considered safe. Nevertheless, many adverse effects associated with LTRAs have been reported. Most of the adverse events are mild (headache, gastrointestinal disorders, pharyngitis, fatigue, upper respiratory tract infection, cutaneous rash, and reversible changes in the serum transaminase levels).